Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 2,241–2,260 of 18,047 drug recalls

Drug Recall Terminated Historical recordClass II

midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-2

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2081-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2080-2

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 5,000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2074-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 2,500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-5

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 1,000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-4

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-3

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2071-2

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2071-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

rocuronium, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6010-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

PHENYLephrine in 0.9% sodium chloride, 1,000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6009-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

PHENYLephrine in 0.9 sodium chloride, 800 mcg/10 mL, (80 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6008-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

PHENYLephrine in 0.9 sodium chloride, 400 mcg/10 mL, (40 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6007-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

lidocaine 2%, 100 mg/5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

ePHEDrine in 0.9% sodium chloride, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, CAPS Inc., Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6004-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-3022-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-7

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Recall initiated
September 21, 2023
Reported by FDA
October 11, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per case, Distributed by RB Health (US), Parsippany, NJ 07054, NDC 63824-431-90

by RB Health (US) LLC

Reason
Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.
Recall initiated
August 29, 2023
Reported by FDA
October 4, 2023
Distribution
USA nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC 62935-753-75, Manufactured by: Tolmar Inc., Fort Collins, CO 80526, For Tolmar Therapeutics Inc., Fort Collins, CO 80526.

by Tolmar, Inc.

Reason
Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
Recall initiated
September 12, 2023
Reported by FDA
October 4, 2023
Distribution
Nationwide in the US.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.